T1D Fund
Venture Capital
Launched in 2016, the first scaled venture fund catalyzing T1D cure-oriented therapies through equity investments in early-stage biotech companies.
Seed
Early Stage
Biotech
Healthcare
- Headquarters
- Boston, United States
- Founded
- 2016
- Website
- t1dfund.org
- AUM
- $200
- Last Investment
- Oct 2025
- Geographic Focus
- United States
Investment Thesis
Co-invests with venture capital and biopharma to de-risk and advance disease-modifying therapies and cures for Type 1 Diabetes, reinvesting all returns.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account